http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_149e8e3aa2d1345e9ac37fca084ef63c
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Ladoire |
| name | Sylvain Ladoire |
| given-name | Sylvain |
| organization-name | Department of Medical Oncology Georges François Leclerc Center Dijon France University of Burgundy, Dijon, France; Platform of Transfer in Cancer Biology, Georges François Leclerc Cancer Center, Dijon, France; Department of Medical Oncology, Georges François Leclerc Center, Dijon, France; Centre de Recherche INSERM LNC-UMR1231, Dijon, France; Genomic and Immunotherapy Medical Institute, Dijon University Hospital, Dijon, France Department of Medical Oncology, Georges Francois Leclerc Cancer Center, Dijon, France; Cancer Biology Genetic and Histology Transfer Platform, Georges Francois Leclerc Cancer Center, Dijon, France; INSERM U866, Dijon, France; University of Bourgogne Franche-Comté, Dijon, France Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 866, Dijon, France; UFR des sciences de santé, Université de Bourgogne, Dijon, France; Centre Georges François Leclerc, Dijon, France Georges François Leclerc Center Dijon France; Université de Bourgogne Dijon France Georges François Leclerc Center, Dijon, France; Université de Bourgogne, Dijon, France. Georges-François Leclerc Cancer Center, Dijon, France Department of Medical Oncology, Georges François Leclerc Center, Dijon, France.; Institut National de la Santé et de la Recherche Médicale, Avenir Team INSERM, CRI-866 University of Burgundy, Dijon, France. 1Centre Régional de Lutte Contre le Cancer and; 2Institut National de la Sante et de la Recherche Medicale CRI-866, Faculty of Medicine, Dijon, France; and Charles Guenancia, Annick Lefebvre, and Yves Cottin, University Hospital; Charles Guenancia, Marianne Zeller, Luc Rochette, Yves Cottin, and Catherine Vergely, Institut National de la Santé et de la Recherche Médicale, U866, Laboratoire de Physiopathologie et Pharmacologie Cardio-Métaboliques; Sylvain Ladoire and François Ghiringhelli, Georges François Leclerc Cancer Center; Sylvain Ladoire and François Ghiringhelli, Institut National de la Santé et de la Recherche Médicale, CRI-866, University of... Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.; Université Bourgogne Franche-Comté, Dijon, France.; Centre Georges François Leclerc, Dijon, France. Department of Medical Oncology, Georges François Leclerc Center; Dijon, France; Institut National de la Santé et de la Recherche Médicale; U1015, Equipe labellisée Ligue Nationale Contre le Cancer; Institut Gustave Roussy, Villejuif, France From the Institut National de la Santé et de la Recherche Médicale (INSERM) U517, INSERM EPI 106, IFR100, Dijon, France; INSERM U362, Institut Gustave Roussy, Villejuif, France; INSERM EMI00-03, Institut Universitaire d'Hematologie, Hopital St Louis, Paris, France; The Rayne Institute, King's College Hospital, London, United Kingdom. Georges François Leclerc Cancer Center, Dijon, France. 1INSERM, U866, Dijon, France.; 2UFR des Sciences de Santé, Université de Bourgogne-Franche Comté, Dijon, France.; 3Centre Georges François Leclerc, Dijon, France.; 4Plateforme de Transfert en Biologie Cancérologique, CGFL, Dijon, France. Department of Medical Oncology, Georges François Leclerc Cancer Center, University of Burgundy, Dijon, France; CHU Dijon‐Bourgogne Georges‐François Leclerc Centre, CGFL Dijon France Department of Clinical Oncology Centre Georges‐François Leclerc Dijon France Department of Medical Oncology, Center GF Leclerc, Dijon, France; Plateform Transfer in Biological Oncology, Dijon, France Georges François Leclerc Center, Dijon, France; Université de Bourgogne, Dijon, France Georges François Leclerc Center, University of Burgundy, Dijon, France Authors' Affiliations: 1Institut National de la Santé et de la Recherche Medicale (INSERM), U866; 2Faculté de Médecine, Université de Bourgogne; 3Centre Georges François Leclerc, Dijon; 4University and CNRS, UMR7355, Orléans, France; 5Center for Integrative Genomics, University of Lausanne, Lausanne; 6Division of Neurology, Geneva University Hospital; 7Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland; and 8Institute of Infectious Disease and Molecular Medicine (IIDMM), University of Cape Town, Cape Town, Republic of South Africa; Authors' Affiliations: 1Institut National de la Santé et de la Recherche Medicale (INSERM), U866; 2Faculté de Médecine, Université de Bourgogne; 3Centre Georges François Leclerc, Dijon; 4University and CNRS, UMR7355, Orléans, France; 5Center for Integrative Genomics, University of Lausanne, Lausanne; 6Division of Neurology, Geneva University Hospital; 7Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland; and 8Institute of Infectious Disease and Molecular Medicine (IIDMM), University of Cape Town, Cape Town, Republic of South Africa; Authors' Affiliations: 1Institut National de la Santé et de la Recherche Medicale (INSERM), U866; 2Faculté de Médecine, Université de Bourgogne; 3Centre Georges François Leclerc, Dijon; 4University and CNRS, UMR7355, Orléans, France; 5Center for Integrative Genomics, University of Lausanne, Lausanne; 6Division of Neurology, Geneva University Hospital; 7Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland; and 8Institute of Infectious Disease and Molecular Medicine (IIDMM), University of Cape Town, Cape Town, Republic of South Africa Centre Georges François Leclerc, Dijon, France Center Georges-François Leclerc, Dijon, France Associate Professor, UMR 1347, pôle Microbiologie Environnementale et Risque Sanitaire, Université de Bourgogne, Faculté de Médecine, Dijon, France. a Department of Medical Oncology, EA 4184, Georges François Leclerc Center, Dijon, France; b Institut National de la Santé et de la Recherche Médicale, Avenir Team INSERM, CRI-866 University of Burgundy, Dijon, France; INSERM, U866, Faculté de Médecine, Université de Bourgogne, Dijon, France; Centre Georges-François Leclerc, Dijon, France Institut National de la Santé et de la Recherche Médicale, Villejuif, France.; Institut de Cancérologie Gustave Roussy, Villejuif, France.; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France. Authors' Affiliations: 1INSERM Research Center 866, AVENIR Team; 2Faculty of Medicine, University of Burgundy, 3Anti-Cancer Center, Georges François Leclerc, Dijon, France; and 4Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Authors' Affiliations: 1INSERM Research Center 866, AVENIR Team; 2Faculty of Medicine, University of Burgundy, 3Anti-Cancer Center, Georges François Leclerc, Dijon, France; and 4Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Authors' Affiliations: 1INSERM Research Center 866, AVENIR Team; 2Faculty of Medicine, University of Burgundy, 3Anti-Cancer Center, Georges François Leclerc, Dijon, France; and 4Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts Centre Georges-François Leclerc, Dijon, France. Department of Medical Oncology, Georges François Leclerc Cancer Center – UNICANCER, 1 rue Professeur Marion, Dijon, 21000, France Center Georges-François Leclerc, Dijon, France. University of Burgundy, Centre Georges François Leclerc, Department of Medical Oncology, Dijon, France. Medical Oncology Unit, Georges François Leclerc Comprehensive Cancer Centre - UNICANCER, Dijon, Bourgogne-Franche-Comté, France. Chemotherapy and Immune Response Team, Lipides Nutrition Cancer, Dijon, Bourgogne-Franche-Comté, France. Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France |
Incoming Links
Total number of triples: 180.